Charcot Arthropathy of Foot and Ankle

Abdelatif, Nasef M. N.

doi:10.1007/978-3-031-20987-1_63

Cited by 1 publication

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The same limitation applies to MIS, as benefits were assumed to equal those from open surgery. Regardless, current evidence supports the assumption of comparable patient‐reported outcomes between these treatments, specifically between open and MIS [2] and between MIS and endoscopic FHL transfers [1].…”

Section: Discussionmentioning

confidence: 70%

“…The current study allocated the same benefits to endoscopic FHL transfer patients as other surgical treatments. However, prospectively collected data support the assumption that this treatment will provide at least similar benefits to the other surgical treatments [1, 6]. For example, the Achilles Tendon Total Rupture Score (ATRS) was higher, at a value of 95 ± 4.26, for endoscopic FHL transfer in the study by Batista et al [6] than the values reported for open surgery by Olsson et al [46], with ATRS value of 82 ± 20 and EQ‐5D values of 0.91 ± 0.17.…”

Section: Discussionmentioning

confidence: 99%

“…It was assumed that a healthy person works 42 h per week, with a mean hourly wage of $27 (U.S. national average in 2019) [43], considering a societal perspective in an American setting. Time until return to work (RTW) after open and MIS surgical treatments were the same, as evidence suggests that open and MIS repairs provide similar outcomes [1]. Since specific values for patients subjected to endoscopic FHL transfers are currently unavailable, the same time until RTW for open and MIS surgeries was adopted.…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Early analysis shows that endoscopic flexor hallucis longus transfer has a promising cost-effectiveness profile in the treatment of acute Achilles tendon ruptures

Diniz

Ferreira

Figueiredo³

et al. 2022

Knee Surg Sports Traumatol Arthrosc

View full text Add to dashboard Cite

Purpose Current options for treating an Achilles tendon rupture (ATR) include conservative and surgical approaches. Endoscopic lexor hallucis longus (FHL) transfer has been recently proposed to treat acute ruptures, but its cost-efectiveness potential remains to be evaluated. Therefore, the objective of this study was to perform an early cost-efectiveness analysis of endoscopic FHL transfer for acute ATRs, comparing the costs and beneits of current treatments from a societal perspective. Methods A conceptual model was created, with a decision tree, to outline the main health events during the treatment of an acute ATR. The model was parameterized using secondary data. A systematic review of the literature was conducted to gather information on the outcomes of current treatments. Data related to outcomes of endoscopic FHL transfers in acute Achilles ruptures was obtained from a single prospective study. Analysis was limited to the two irst years. The incremental cost-efectiveness ratio was the main outcome used to determine the preferred strategy. A willingness-to-pay threshold of $100,000 per quality-adjusted life-year was used. Sensitivity analyses were performed to determine whether changes in input parameters would cause signiicant deviation from the reference case results. Speciically, a probability sensitivity analysis was conducted using Monte Carlo simulations, and a one-way sensitivity analysis was conducted by sequentially varying each model parameter within a given range. Results For the reference case, incremental cost-efectiveness ratios exceeded the willingness-to-pay threshold for all the surgical approaches. Overall, primary treatment was the main cost driver. Conservative treatment showed the highest direct costs related to the treatment of complications. In the probabilistic sensitivity analysis, at a willingness-to-pay threshold of $100,000, open surgery was cost-efective in 50.9%, minimally invasive surgery in 55.8%, and endoscopic FHL transfer in 72% of the iterations. The model was most sensitive to parameters related to treatment utilities, followed by the costs of primary treatments. Conclusion Surgical treatments have a moderate likelihood of being cost-efective at a willingness-to-pay threshold of $100,000, with endoscopic FHL transfer showing the highest likelihood. Following injury, interventions to improve healthrelated quality of life may be better suited for improved cost-efectiveness. Level of evidence Level III.

show abstract

Section: Discussionmentioning

confidence: 70%